ARA-290 is a small peptide derived from the structure of erythropoietin (EPO) and designed to selectively engage tissue-protective signaling pathways without the hematopoietic effects typically associated with EPO. In research settings, ARA-290 is primarily investigated for its interaction with the so-called innate repair receptor (IRR) and tissue-protective receptor (TPR), where it has been shown in preclinical and early clinical studies to influence inflammatory signaling, vascular repair mechanisms, neuropathic pain pathways, and wound-healing processes.

For research use only — not for human consumption.

 

Specifications

 

• Compound: ARA-290

• Category/Target: Erythropoietin (EPO) and designed to selectively engage tissue-protective signaling pathways without the hematopoietic effects typically associated with EPO.

• Form / appearance: Lyophilized powder, white to off-white

• Amount: 10mg per vial

• Purity: ≥99%

• Storage (lyophilized): Cool, dry place away from light

• Storage (after reconstitution): Refrigerate; use promptly per internal SOP

 

What’s Included

 

• 1 × ARA-290 10mg vial (no diluent/solvent)

 

Handling

 

Use an appropriate, compatible solvent per your protocol and laboratory SOPs. Confirm solubility in the intended vehicle and, if required, pass through a sterile filter (0.22 µm) under aseptic technique.

Research Snapshot

 

• Preclinical and translational research has examined ARA-290 in models of vascular injury, islet transplantation, autoimmune conditions, neuropathic pain, and small fiber neuropathy, making it a versatile tool for studying tissue protection and immune modulation.

 

Compliance

 

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.

 

MOTS-c 10mg (≥99% purity). Lyophilized in a sterile, sealed vial for controlled laboratory research. Diluent not included. For research use only. Not for human consumption. 

MOTS-c 10MG

Research-grade mitochondrial-derived peptide prepared for consistency and clear documentation in professional lab workflows.

 

Specifications

 

 

• Compound: MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c)

• Category/Pathway: Mitochondrial-derived peptide studied in AMPK and metabolic-stress signaling

• Form and appearance: Lyophilized powder, white to off-white

• Amount: 10mg per vial

• Purity: ≥99%

• Storage, lyophilized: Cool, dry, protected from light

• Storage, after reconstitution: Refrigerate and use promptly per internal SOP

 

 

What’s Included

 

 

• 1 × MOTS-c 10mg vial (no diluent)

 

 

Handling

 

Use an appropriate sterile diluent and aseptic technique. Follow your lab SOPs for reconstitution, aliquoting, labeling, and disposal.

 

Research Snapshot

 

 

• Reported to activate AMPK and support metabolic flexibility under stress conditions in cell and rodent models, with downstream effects on glucose and fatty-acid handling

• Preclinical studies describe improvements in insulin sensitivity, exercise capacity, and mitochondrial homeostasis in diet-induced models

• Early human investigations are limited and exploratory; protocols vary by dose, route, and training status

• Study-reported observations include expected peptide-class events such as injection-site reactions and transient GI or flushing responses in some settings; compound remains investigational

Compliance

 

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.

Lipo-C 216 mg/mL in a 10 mL sterile solution (≥99% purity). Ready for controlled laboratory research. For research use only. Not for human consumption.

Specifications

 

 

• Type: Sterile aqueous solution 

• Concentration: 216 mg/mL

• Volume: 10 mL

• Total content: 2,160 mg

• Purity: ≥99%

• Packaging: Sterile glass vial, flip-off cap

• Storage (unopened): Cool, dry, protected from light

• After opening: Refrigerate and use promptly per internal SOP

 

 

What’s Included

 

 

• 1 × Lipo-C 216 mg/mL, 10 mL sterile vial

 

 

Handling

 

Use aseptic technique. Do not use if solution is discolored or contains particulates. Follow your lab SOPs for labeling, aliquoting, and disposal. Confirm compatibility with intended diluents or co-formulations before mixing.

 

Research Snapshot

 

 

• Lipotropic research examines compounds that influence fatty-acid mobilization, β-oxidation, methylation flux, and hepatic lipid transport.

• Representative pathways include acyl-carnitine shuttling for mitochondrial entry, phosphatidylcholine-dependent VLDL assembly for lipid export, and one-carbon metabolism for methyl-donor availability.

• Experimental readouts commonly track shifts in acyl-CoA/CoA ratios, respiration and ATP output, and lipid handling markers in cell and animal models.

• Findings are protocol dependent and vary by model, dose, and exposure time.

 

 

Compliance

 

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.

Bacteriostatic Water 30 mL (0.9% benzyl alcohol). Sterile, multi-dose diluent for controlled laboratory reconstitution and dilution. For research use only — not for human consumption.

Sterile bacteriostatic water formulated with 0.9% benzyl alcohol preservative for repeated withdrawals in professional lab workflows.

 

Key Features

 

 

• Fill volume: 30 mL per vial

• Preservative: 0.9% benzyl alcohol (bacteriostatic)

• Clear, colorless sterile diluent

• Multi-dose rubber stopper for multiple draws per SOP

• Tamper-evident flip cap with lot/batch labeling

 

 

Specifications

 

 

• Composition: Purified water + 0.9% benzyl alcohol

• Appearance: Clear, particle-free solution

• Packaging: Sterile glass vial, rubber stopper, flip-off cap

• Typical pH: ~5.0–7.0

• Storage (unopened): Cool, dry, protected from light

• After first puncture: Refrigerate and use within your lab’s defined in-use period

 

 

What’s Included

 

 

• 1 × BAC Water 30 mL sterile vial

 

 

Handling

 

Disinfect the stopper before each withdrawal and use aseptic technique. Do not use if solution is cloudy, discolored, or contains particulates. Verify compatibility with the target compound and vehicle. Follow lab SOPs for reconstitution, labeling, aliquoting, and disposal.

 

Research Snapshot

 

 

• Bacteriostasis: 0.9% benzyl alcohol suppresses bacterial growth, enabling multiple sterile withdrawalsfrom a single vial.

• Use cases: Commonly employed to reconstitute or dilute lyophilized materials for in-vitro assays, stability testing, or method development.

• Cautions: Preserved diluents are not intended for neonatal applications in clinical contexts; labs typically enforce a limited in-use window after first puncture and strict asepsis.

 

 

Compliance

 

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.

Cagrilintide 10mg (99% purity). Lyophilized in a sterile, sealed vial for controlled laboratory research. Diluent not included. For research use only — not for human consumption.

CAGRILINTIDE 10MG

Research-grade amylin-pathway compound  prepared for consistency and clear documentation in professional lab workflows.

Specifications

 

 

• Compound: Cagrilintide

• Class/Target: Long-acting amylin receptor agonist (calcitonin receptor + RAMP complexes)

• Form/Appearance: Lyophilized powder, white to off-white

• Amount: 10mg per vial

• Purity: ≥99%

• Storage (lyophilized): Cool, dry, away from light

• Storage (after reconstitution): Refrigerate and use promptly per internal SOP

 

 

What’s Included

 

 

• 1 × Cagrilintide 10mg vial (no diluent)

 

 

Handling

 

Use an appropriate sterile diluent and aseptic technique. Follow your lab SOPs for reconstitution, aliquoting, labeling, and disposal.

 

Research Snapshot

 

 

• Amylin receptor agonism has been shown to reduce energy intake and body weight in preclinical models and randomized human studies, with effects attributed to enhanced satiety and delayed gastric emptying.

• Cagrilintide is an acylated, long-acting analog designed for extended exposure in once-weekly study protocols via albumin binding.

• Combination protocols pairing an amylin-pathway agonist with a GLP-1 receptor agonist have reported additive weight-loss effects versus either agent alone in clinical trials.

• The most common study-reported adverse events are gastrointestinal, including nausea and vomiting, typically mitigated by dose titration.

• Cagrilintide remains investigational and is not approved for medical use.

 

 

Compliance

 

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.

BPC157 5mg + TB500 5mg (99% purity). Lyophilized  blend in a sterile, sealed vial for controlled laboratory research. Diluent not included. For research use only — not for human consumption.

BPC157 5MG + TB500 5MG

Research-grade dual-blend prepared for consistency and clean documentation in professional lab workflows.

 

Specifications

 

• Compounds:

  • BPC157 (Body-Protection Compound, gastric pentadecapeptide fragment) — 5mg

  • TB500 (thymosin beta-4 research compound ) — 5mg

   

• Form / appearance: Lyophilized powder, white/off-white

• Purity: ≥99%

• Packaging: Sterile glass vial, flip-off cap

• Storage (lyophilized): Cool, dry, away from light

• Storage (after reconstitution): Refrigerate; use promptly per internal SOP

 

What’s Included

 

• 1 × BPC157 5mg + TB500 5mg vial (no diluent)

 

Handling

 

Use an appropriate sterile diluent and aseptic technique. Follow your lab’s SOPs for reconstitution, aliquoting, labeling, and disposal.

Research Snapshot

 

• BPC157: Preclinical studies report support for angiogenic signaling, tendon/ligament and GI mucosal models, and modulation of nitric-oxide pathways; data are largely animal/cell-based with limited controlled human evidence.

• TB500 (thymosin beta-4 class): Investigated for cell migration, actin regulation, angiogenesis, and tissue repair in cell/animal models; early human exploration is mixed and indication-specific.

• Combination: Used in method-development research where complementary cytoskeletal/angiogenicpathways are of interest; synergy is not establishedand outcomes are protocol-dependent.

• Both compounds remain investigational and are not approved for medical use.

 

Compliance

 

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.

 

 

KLOW Blend 80mg combining BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg, and KPV 10mg at ≥99% purity. Lyophilized coumpound plus copper tripeptide blend in a sterile, sealed vial for controlled laboratory research. Diluent not included. For research use only. Not for human consumption.

KLOW BLEND 80MG

Research-grade multi-component blend prepared for consistency and clear documentation in professional lab workflows.

Specifications

 

 

• Compounds and amounts:

   

  • BPC-157 (pentadecapeptide) — 10mg

  • TB-500 (thymosin beta-4 research peptide) — 10mg

  • GHK-Cu (Gly-His-Lys•Cu²⁺ complex) — 50mg

  • KPV (Lys-Pro-Val tripeptide) — 10mg

   

• Form and appearance: Lyophilized powders, white to light blue (GHK-Cu may impart a faint blue hue)

• Purity: ≥99%

• Packaging: Sterile glass vial, flip-off cap

• Storage, lyophilized: Cool, dry, away from light

• Storage, after reconstitution: Refrigerate and use promptly per internal SOP

 

 

What’s Included

 

 

• 1 × KLOW Blend 80mg vial (no diluent)

 

 

Handling

 

Use an appropriate sterile diluent and aseptic technique. Confirm solubility and compatibility for each component before combining. Follow your lab’s SOPs for reconstitution, aliquoting, labeling, and disposal.

 

Research Snapshot

 

 

• BPC-157: Preclinical models describe pro-repair signaling with angiogenic support, nitric-oxide pathway modulation, and favorable effects in tendon, ligament, and GI mucosal paradigms.

• TB-500: Investigated for actin-mediated cell migration, angiogenesis, and tissue-repair signaling in cell and animal systems.

• GHK-Cu: Studied for extracellular matrix remodeling, collagen and elastin support, and antioxidant or anti-inflammatory gene programs in skin and wound models.

• KPV: Explored for anti-inflammatory activity, including NF-κB modulation, reduced pro-inflammatory cytokines, and support of epithelial barrier integrity in cell and animal models.

• Blend context: Used in method-development settings where angiogenic, cytoskeletal, ECM, and anti-inflammatory pathways are jointly explored. Synergy is not established and outcomes are protocol dependent.

 

 

Compliance

 

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.

 

Bacteriostatic Water 10 mL (0.9% benzyl alcohol). Sterile, multi-dose diluent for controlled laboratory reconstitution and dilution. For research use only — not for human consumption.

BAC WATER 10ML

Sterile bacteriostatic water formulated with 0.9% benzyl alcohol preservative for repeated withdrawals in professional lab workflows.

Specifications

 

 

• Composition: Purified water + 0.9% benzyl alcohol

• Appearance: Clear, particle-free solution

• Packaging: Sterile glass vial, rubber stopper, flip-off cap

• Typical pH: ~5.0–7.0

• Storage (unopened): Cool, dry, away from light

• After first puncture: Refrigerate and use within the in-use period defined by your internal SOP

 

 

What’s Included

 

 

• 1 × BAC Water 10 mL sterile vial

 

 

Handling

 

Disinfect the stopper before each withdrawal. Use aseptic technique. Do not use if cloudy, discolored, or if particulates are present. Confirm compatibility with target compound and final vehicle. Follow lab SOPs for labeling, aliquoting, and disposal.

 

Research Snapshot

 

 

• Bacteriostasis: 0.9% benzyl alcohol suppresses bacterial growth, enabling multiple sterile withdrawalsfrom a single vial.

• Use cases: Commonly used to reconstitute or dilute lyophilized materials prior to in-vitro assays, stability testing, or method development.

• Cautions: Preserved diluents are not intended for neonatal applications in clinical contexts; labs typically enforce a limited in-use window after first puncture and strict asepsis.

 

 

Compliance

 

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.

 

 

Bacteriostatic Water 3 mL (0.9% benzyl alcohol). Sterile, multi-dose diluent for controlled laboratory reconstitution and dilution. For research use only — not for human consumption.

BAC WATER 3ML

Sterile bacteriostatic water formulated with 0.9% benzyl alcohol preservative for multi-withdrawal use in professional lab workflows.

 

Specifications

 

 

• Composition: Purified water with 0.9% benzyl alcohol

• Appearance: Clear, colorless solution

• Packaging: Sterile glass vial, rubber stopper, flip-off cap

• pH (typical): ~5.0–7.0 (solution)

• Storage (unopened): Cool, dry, away from light

• After first puncture: Use aseptic technique; store refrigerated and discard per your internal SOP for multi-dose diluents

 

 

What’s Included

 

 

• 1 × BAC Water 3 mL sterile vial

 

 

Handling

 

Disinfect the stopper before each withdrawal. Do not use if solution is cloudy, discolored, or contains particulates. Confirm compatibility with the target compound and final vehicle. Follow your lab’s SOPs for labeling, aliquoting, and disposal.

 

Research Snapshot

 

 

• Bacteriostasis: 0.9% benzyl alcohol inhibits bacterial growth, allowing multiple sterile withdrawals from a single vial in laboratory settings.

• Use case: Commonly employed to reconstitute or dilute lyophilized materials prior to in-vitro assays, stability studies, or method development.

• Cautions: Benzyl alcohol–preserved solutions are not intended for neonatal applications in clinical contexts; labs typically set a limited in-use period after first puncture and maintain strict asepsis.

 

 

Compliance

 

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.